Repligen Corporation Shs Unsponsored Brazilian Depositary Receipt Repr 0.033333 Sh (R2GE34) Price & Analysis

― Followers

R2GE34 Stock Chart & Stats

R$23.78

-R$1.10(-4.42%)

Jul 29, 2026

―

Day’s Range― - ―

52-Week RangeR$18.44 - R$31.02

Previous CloseN/A

VolumeN/A

Average Volume (3M)0.00

Market Cap

R$42.07B

Enterprise ValueR$30.90K

Total Cash (Recent Filing)N/A

Total Debt (Recent Filing)N/A

Price to Earnings (P/E)181943.4

Beta0.15

Next Earnings

Nov 03, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)0.00

Shares Outstanding56,435,620

10 Day Avg. Volume0

30 Day Avg. Volume0

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Repligen Corporation Shs Unsponsored Brazilian Depositary Receipt Repr 0.033333 Sh News

Repligen price target raised to $175 from $165 at JPMorgan

JPMorgan raised the firm’s price target on Repligen (RGEN) to $175 from $165 and keeps an Overweight rating...

1d ago

RGEN

Repligen rises 15.4%

Repligen (RGEN) is up 15.4%, or $20.22 to $151.28. Published first on TheFly – the ultimate source for...

2d ago

RGEN

Repligen rises 16.2%

Repligen (RGEN) is up 16.2%, or $21.23 to $152.29. Published first on TheFly – the ultimate source for...

2d ago

RGEN

Repligen reports Q2 adjusted EPS 54c, consensus 45c

Reports Q2 revenue $204.13M, consensus $201.4M. Olivier Loeillot, President and Chief Executive Officer of Repligen (RGEN) said, “We...

2d ago

RGEN

Repligen raises FY26 EPS view to $2.03-$2.09 from $1.97-$2.05, consensus $2.00

Raises FY26 revenue view to $813M-$835M from $803M-$833M, consensus $821.04M. The company said, “Our financial guidance for the...

2d ago

RGEN

Midday Fly By: AT&T reports Q2 beat, AMD invests $5B in Anthropic

The major averages were mixed near noon as traders take a cautious approach ahead of key earnings reports...

8d ago

BioLife Solutions downgraded to Hold from Buy at Lake Street

Lake Street downgraded BioLife Solutions (BLFS) to Hold from Buy with a price target of $31, down from...

8d ago

BLFS

RGEN

Repligen to acquire BioLife Solutions for $31 per share, or $1.5B

06:01 EDT Repligen (RGEN) to acquire BioLife Solutions (BLFS) for $31 per share, or $1.5B Published first on...

8d ago

BLFS

RGEN

Repligen to acquire BioLife Solutions for $31 per share, or $1.5B

Repligen (RGEN) and BioLife Solutions (BLFS) announced they have entered into a definitive agreement under which Repligen, subject...

8d ago

BLFS

RGEN

Repligen’s Operational Momentum Offset by Full Valuation; Kyle Mikson CFA Reiterates Hold with Unchanged $145 Price Target

Repligen, the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Kyle Mikson CFA from...

1d ago

RGEN

Repligen Earns Buy Rating on Strong Q2 Beat, Raised Guidance, and Broad-Based Demand Strength

William Blair analyst Matt Larew has maintained their bullish stance on RGEN stock, giving a Buy rating on...

2d ago

RGEN

Repligen Earns Buy Rating on BioLife Acquisition Synergies and Strong Organic Growth

William Blair analyst Matt Larew has maintained their bullish stance on RGEN stock, giving a Buy rating on...

8d ago

RGEN

R2GE34 FAQ

What was Repligen Corporation Shs Unsponsored Brazilian Depositary Receipt Repr 0.033333 Sh’s price range in the past 12 months?

Repligen Corporation Shs Unsponsored Brazilian Depositary Receipt Repr 0.033333 Sh lowest stock price was R$18.44 and its highest was R$31.02 in the past 12 months.

What is Repligen Corporation Shs Unsponsored Brazilian Depositary Receipt Repr 0.033333 Sh’s market cap?

Repligen Corporation Shs Unsponsored Brazilian Depositary Receipt Repr 0.033333 Sh’s market cap is R$42.07B.

When is Repligen Corporation Shs Unsponsored Brazilian Depositary Receipt Repr 0.033333 Sh’s upcoming earnings report date?

Repligen Corporation Shs Unsponsored Brazilian Depositary Receipt Repr 0.033333 Sh’s upcoming earnings report date is Nov 03, 2026 which is in 96 days.

How were Repligen Corporation Shs Unsponsored Brazilian Depositary Receipt Repr 0.033333 Sh’s earnings last quarter?

Repligen Corporation Shs Unsponsored Brazilian Depositary Receipt Repr 0.033333 Sh released its earnings results on Jul 28, 2026. The company reported R$0 earnings per share for the quarter, the consensus estimate of N/A by R$0.

Is Repligen Corporation Shs Unsponsored Brazilian Depositary Receipt Repr 0.033333 Sh overvalued?

According to Wall Street analysts Repligen Corporation Shs Unsponsored Brazilian Depositary Receipt Repr 0.033333 Sh’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Repligen Corporation Shs Unsponsored Brazilian Depositary Receipt Repr 0.033333 Sh pay dividends?

Repligen Corporation Shs Unsponsored Brazilian Depositary Receipt Repr 0.033333 Sh does not currently pay dividends.

What is Repligen Corporation Shs Unsponsored Brazilian Depositary Receipt Repr 0.033333 Sh’s EPS estimate?

Repligen Corporation Shs Unsponsored Brazilian Depositary Receipt Repr 0.033333 Sh’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Repligen Corporation Shs Unsponsored Brazilian Depositary Receipt Repr 0.033333 Sh have?

Repligen Corporation Shs Unsponsored Brazilian Depositary Receipt Repr 0.033333 Sh has 56,435,620 shares outstanding.

What happened to Repligen Corporation Shs Unsponsored Brazilian Depositary Receipt Repr 0.033333 Sh’s price movement after its last earnings report?

Repligen Corporation Shs Unsponsored Brazilian Depositary Receipt Repr 0.033333 Sh reported an EPS of R$0 in its last earnings report, expectations of N/A. Following the earnings report the stock price went up 12.274%.

Which hedge fund is a major shareholder of Repligen Corporation Shs Unsponsored Brazilian Depositary Receipt Repr 0.033333 Sh?

Currently, no hedge funds are holding shares in BR:R2GE34

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology